Skip to main content

Table 3 Summary of the CCL7 in kidney disease in this review article

From: CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease

Kidney disease References
ESRD Exhibit mycobacterium tuberculosis-specific CCL7 expression [62]
Nephrolithiasis CCL7 in papillary tips, kidney urine, and bladder urine ↑ [63]
Nephritis CCL7 ↑ Macrophage and T lymphocyte infiltration ↑ [64,65,66]
Kidney fibrosis CCL7 ↑ CCL7 could be up-regulated by TGF-β1 [67, 68]
Acute kidney injury CCL7 (B cell) ↑ Facilitate neutrophil and monocyte recruitment ↑ [69]
Kidney stone Oxalate upregulates CCL7 expressions in the human renal proximal tubular epithelial cells [70]
Urinary obstruction Oncostatin M treatment upregulates CCL7 mRNA in kidney fibroblasts/ kidney tubular interstitial fibrosis ↑ [71,72,73]
Diabetic kidney disease Urinary expressions CCL7 in type 1 diabetes ↑ [51]
  1. ESRD end-stage renal disease, TGF-β transforming growth factor-β